Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
Key Takeaways on Wegovy Insurance Coverage FDA-approved for weight management : Wegovy (semaglutide 2.4mg) is approved for chronic weight management in adults with BMI 30, or BMI 27 with at least one weight-related comorbidity Commercial insurance coverage is expanding : About 40-50% of employer-sponsored plans now cover GLP-1 medications for weight loss, up from under 20% in 2023 Medicare does NOT cover Wegovy for weight loss : Federal law prohibits Medicare Part D from covering drugs prescribed solely for weight management no exceptions List price without insurance : Approximately $1,349/month ($16,188/year) at retail pharmacy Savings programs available : Novo Nordisk offers a savings card reducing cost to as low as $0-$25/month for eligible commercially insured patients Wegovy is a once-weekly injectable prescription medication containing semaglutide at the 2.4mg dose, manufactured by Novo Nordisk
130 mg/26 mL (5 mg/mL) solution in a single-dose vial for IV use (all three presentations approved as interchangeable) Recommended dosage is based on indication, patient age and body weight Starjemza will be available from Bio-Thera/Hikma with launch time frame TBD June 3, 2025 darolutamide (Nubeqa) Bayer
A 10 mg vial covers 1-4 weekly doses depending on the dose step
Navigating Tirzepatide Insurance Coverage and Cost in Chandler Klinic's telehealth platform in Chandler, Arizona, offers comprehensive insurance handling for tirzepatide prescriptions
p = 0.22) to 4.99 (95% CI: 1.148.84
